Latest AI and machine learning research in chemotherapy for healthcare professionals.
Dengue causes approximately 10.000 deaths and 100Â million symptomatic infections annually worldwide,...
Despite recent advances in cancer treatment, refining therapeutic agents remains a critical task for...
BACKGROUND: Pathological complete response (pCR) is an essential criterion for adjusting follow-up t...
Surfactants as synergistic agents are necessary to improve the stability and utilization of pesticid...
PURPOSE: Developed and validated a deep learning radiomics nomogram using multi-phase contrast-enhan...
Predicting distant recurrence of endometrial cancer (EC) is crucial for personalized adjuvant treatm...
PURPOSE: This study aimed to assess tumor regression grade (TRG) in patients with rectal cancer afte...
BACKGROUND: Sintilimab plus chemotherapy has proven effective as a combination immunotherapy for pat...
Lung cancer is categorized into two main types: non-small cell lung cancer (NSCLC) and small cell lu...
Platinum-based chemotherapy is the cornerstone treatment for female high-grade serous ovarian carcin...
BACKGROUND: Primary pancreatic signet ring cell carcinoma (PSRCC), an extremely rare histologic vari...
BACKGROUND: Advanced unresectable gastric cancer (GC) patients were previously treated with chemothe...
BACKGROUND AND OBJECTIVES: Deep learning models (DLMs) are applied across domains of health sciences...
BACKGROUND AND PURPOSE: species are well-known antifungal medicinal plants. (Apiaceae family) is a...
BACKGROUND: Rectal tumors display varying degrees of response to total neoadjuvant therapy (TNT). We...
Image-based deep learning models are used to extract new information from standard hematoxylin and e...
Clinical trials involving systemic neoadjuvant treatments in breast cancer aim to shrink tumors befo...
BACKGROUND: Although separate analysis of individual factor can somewhat improve the prognostic perf...
The cited article reports on a convolutional neural network trained to predict response to neoadjuva...
BACKGROUND: The survival advantage of neoadjuvant systemic therapy (NST) for breast cancer patients ...
INTRODUCTION: Peritoneal carcinomatosis is considered a late-stage manifestation of neoplastic disea...